Learn More
Medchemexpress LLC 8-(3,5-difluoro-2-pyridinyl)-N-[11-[[(2S)-1-[(2S,4R)-4-hydroxy-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl | 2417371-71-0 | MFCD32689578 | 100.0% | C56H67F2N9O8S2 | 10MG

Supplier: Medchemexpress LLC HY129937A10MG
GNE-987 is a proteolysis targeting chimera (PROTAC) that recruits the VHL E3 ligase to induce targeted degradation of BRD4. It displays picomolar cellular degradation potency and low-nanomolar bromodomain binding, making it suitable for mechanistic studies of BRD4 biology and PROTAC development.
- Induces potent BRD4 degradation at picomolar concentrations
- Binds BD1 and BD2 bromodomains with low-nanomolar affinity
- Applicable for PROTAC-antibody conjugate development
- High reported purity suitable for biochemical studies
- Soluble in DMSO and formulatable for in vivo dosing
- Recommended storage under inert atmosphere at low temperatures
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.